Key Points Tempus AI specializes in developing artificial intelligence solutions to improve patient outcomes in various healthcare fields. Ark Invest reduced the Tempus AI position in the ARK Innovation ETF. Tempus AI still holds a significant weighting in the ARK Genomic Revolution ETF. 10 stocks we like better than Tempus AI › Prior to the start of this week, Tempus AI (NASDAQ: TEM) stock had locked in a 161% gain since the start of the year -- an impressive performance for the healthcare compa ...

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. On Tuesday, Cathie Wood-led Ark Invest made a notable decision by selling shares of Tempus AI Inc. (NASDAQ:TEM), marking a significant move in their investment strategy. The Tempus AI Trade Ark Invest sold 62,352 shares of Tempus AI (Pre-Reincorporation) through the ARK Innovation ETF (BATS:ARKK). The shares were sold at a closing price of $84.13, amounting to a transaction value of approximately $5.2 mill ...

On Tuesday, Cathie Wood-led Ark Invest made a notable decision by selling shares of Tempus AI Inc. TEM, marking a significant move in their investment strategy.The Tempus AI TradeArk Invest sold 62,352 shares of Tempus AI (Pre-Reincorporation) through the ARK Innovation ETF ARKK. The shares were sold at a closing price of $84.13, amounting to a transaction value of approximately $5.2 million. This move comes after Tempus AI recently received FDA 510(k) clearance for its RNA-based Tempus xR IVD device, a sig ...